Variant ID: 8-6364922-T-C

NM_001118887.1(ANGPT2):c.1327+1531A>G

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.

Plos One
Makhoul, Issam I; Todorova, Valentina K VK; Siegel, Eric R ER; Erickson, Stephen W SW; Dhakal, Ishwori I; Raj, Vinay R VR; Lee, Jeannette Y JY; Orloff, Mohammed S MS; Griffin, Robert J RJ; Henry-Tillman, Ronda S RS; Klimberg, Suzanne S; Hutchins, Laura F LF; Kadlubar, Susan A SA
Publication Date: 2017

Variant appearance in text: rs2515409
PubMed Link: 28045923
Variant Present in the following documents:
  • Main text
View BVdb publication page



Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery.

Plos One
Miaskowski, Christine C; Dodd, Marylin M; Paul, Steven M SM; West, Claudia C; Hamolsky, Deborah D; Abrams, Gary G; Cooper, Bruce A BA; Elboim, Charles C; Neuhaus, John J; Schmidt, Brian L BL; Smoot, Betty B; Aouizerat, Bradley E BE
Publication Date: 2013

Variant appearance in text: rs2515409
PubMed Link: 23613720
Variant Present in the following documents:
  • Main text
View BVdb publication page